Global Endowment Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-91,500
Closed -$5.89M 223
2018
Q2
$5.89M Buy
91,500
+24,000
+36% +$1.58M 0.77% 36
2018
Q1
$4.2M Buy
67,500
+18,000
+36% +$1.29M 0.6% 33
2017
Q4
$3.59M Buy
49,500
+8,900
+22% +$647K 0.52% 30
2017
Q3
$3.3M Sell
40,600
-1,200
-3% -$94.9K 0.47% 42
2017
Q2
$3.36M Buy
41,800
+2,800
+7% +$221K 0.46% 33
2017
Q1
$3.06M Buy
39,000
+2,700
+7% +$216K 0.45% 41
2016
Q4
$2.86M Buy
+36,300
New +$2.94M 0.44% 33

Other funds holding CVS

Global Endowment Management's CVS Position: Q3 2018 in Review

Global Endowment Management sold out of CVS Health (CVS) in Q3 2018, closing a stake of 91,500 shares — an estimated $5.89M sold.

Global Endowment Management first reported a position in CVS in Q4 2016 and held it in 7 quarters. The position peaked at $5.89M in Q2 2018. 1,599 funds tracked by Wall St. Rank hold CVS as of Q3 2018.

  • Global Endowment Management reported no remaining CVS Health position as of Q3 2018 after selling out during the quarter.
  • Global Endowment Management sold 91,500 CVS Health shares in Q3 2018, an estimated $5.89M.
  • Global Endowment Management first reported a position in CVS Health in Q4 2016 and held it in 7 quarters.
  • Global Endowment Management's CVS Health position peaked at $5.89M in Q2 2018.
  • 1,599 funds tracked by Wall St. Rank held CVS Health as of Q3 2018.

Based on Global Endowment Management's 13F filing for Q3 2018, filed 9 Nov 2018.